The @injective Foundation plans to invest up to $15 million in Canary Capital's injective-protocol:native staking ETF at $25 per share as seed capital. The fund aims to list on Nasdaq under the ticker symbol #INJC This is great ninja news and a very special focus on receiving staking rewards that are reinvested directly into the fund. Commissions: - Annual sponsor fee 1.10% - 30% of staking rewards go to commissions, providers, custodian, sponsor, the fund retains 70% of the rewards. The Injective Foundation buys shares for injective-protocol:native, which shows direct support and gives the fund start-up capital. This is the first US-listed INJ staking ETF; Europe already has #AINJ, which will allow institutional and ordinary investors to gain regulated access to INJ staking through a regular brokerage account without wallets or keys. Registration is still pre-effective - listing and trading are subject to SEC approval. This is a step towards institutionalizing Injective in the US amid growing interest in staking ETFs. I'm confident the next era of decentralized finance is licensed in America.